Currently there are five analysts that rate Questcor Pharmaceuticals a buy no analysts rate it a sell and six rate it a hold TheStreet Ratings rates Questcor Pharmaceuticals as a buy The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and good cash flow from operations
When the Hedge Fund Message board spam bot Michelle_Michelle shows up the bottom is very close. I know from GMCR in August. She spammed that board with negative #$%$ when GMCR was floating btw 17 and 18. Go to high short interest web site and see a list of many of its stocks. I made a bunch of money on GMCR ignoring the short spam bot. I see deja vu with GMCR. Consider that bot exposed and for every long's sanity just ignore and hold strong or add to positions on weakness. Do not get intimidated or scared. Qcor will be just fine.